Y-Intercept (HK)’s Harmony Biosciences HRMY Stock Holding History

Y-Intercept (HK)’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Sell	49,649 -97,395	-66%	-$3.07M	0.04%	756
2026 Q1	$4.12M	Buy	147,044 +107,449	+271%	+$3.52M	0.08%	407
2025 Q4	$1.48M	Sell	39,595 -18,895	-32%	-$621K	0.03%	775
2025 Q3	$1.61M	Buy	58,490 +9,036	+18%	+$311K	0.04%	731
2025 Q2	$1.56M	Buy	+49,454	New	+$1.59M	0.04%	720
2025 Q1	–	Sell	-27,061	Closed	-$931K	–	1375
2024 Q4	$931K	Buy	27,061 +20,070	+287%	+$690K	0.06%	457
2024 Q3	$280K	Buy	+6,991	New	+$246K	0.02%	1047

Other funds holding HRMY

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.25B AUM 34.07% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return